Abstract
Abstract: :
Purpose: To report the use of intravitreal injection of triamcinolone acetonide (TAAC) at the acute phase of Vogt–Koyanagi–Harada's disease. Methods: Nine eyes from five patients at the acute phase of Vogt–Koyanagi–Harada's disease with serous retinal detachments were treated with a 4 mg intravitreal injection of TAAC. The following parameters were evaluated: visual acuity, intraocular pressure, as well as the height of the serous retinal detachment using optical coherence tomography (OCT). Results: OCT images showed a marked decrease in the retinal detachment in the first week after the injection with subsequent return to normal retinal thickness in all eyes. Follow–up ranged from 5 to 12 months with a mean of 7,8 months. No complications were observed. Conclusions: Intravitreal TAAC provides short–term improvement in visual acuity and serous retinal detachments associated with Vogt–Koyanagi–Harada's disease. These findings should be followed by future studies to evaluate long term effects.
Keywords: imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • injection • retinal detachment